Share-based Payment Arrangement, Expense of Bioventus Inc. from 31 Dec 2021 to 27 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bioventus Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2021 to 27 Sep 2025.
  • Bioventus Inc. Share-based Payment Arrangement, Expense for the quarter ending 27 Sep 2025 was $3,176,000, a 27% increase year-over-year.
  • Bioventus Inc. Share-based Payment Arrangement, Expense for the twelve months ending 27 Sep 2025 was $7,920,000.
  • Bioventus Inc. annual Share-based Payment Arrangement, Expense for 2024 was $9,613,000, a 306% increase from 2023.
  • Bioventus Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2,370,000, a 86% decline from 2022.
  • Bioventus Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17,114,000, a 12% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Bioventus Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,920,000 $3,176,000 +$685,000 +27% 29 Jun 2025 27 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $7,235,000 $3,361,000 -$2,201,000 -40% 30 Mar 2025 28 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $9,436,000 $2,414,000 -$177,000 -6.8% 01 Jan 2025 29 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $9,613,000 $1,031,000 29 Sep 2024 31 Dec 2024 10-K 11 Mar 2025 2024 FY
Q3 2024 $2,491,000 30 Jun 2024 28 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $5,562,000 31 Mar 2024 29 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $2,591,000 01 Jan 2024 30 Mar 2024 10-Q 07 May 2024 2024 Q1

Bioventus Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $9,613,000 +$7,243,000 +306% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025 2024 FY
2023 $2,370,000 -$14,744,000 -86% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
2022 $17,114,000 -$2,390,000 -12% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2025 2024 FY
2021 $19,504,000 01 Jan 2021 31 Dec 2021 10-K 12 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.